Contribution of β-lactamase production to the resistance of mycobacteria to β-lactam antibiotics  by Quinting, Birgit et al.
FEBS 18431 FEBS Letters 406 (1997) 275-278 
Contribution of p-lactamase production to the resistance of mycobacteria 
to p-lactam antibiotics 
Birgit Quintinga, Jean-Marc Reyratlb, Didier Monnaie2b, Gianfranco Amicosantec, 
Vladimir Pelicicb, Brigitte Gicquelb, Jean-Marie Frerea, Moreno Gallenia* 
^Centre d'Ingenierie des Proteines, Universite de Liege, Institut de Chimie (B6), B-4000 Sart Tilman, Liege 1, Belgium 
b Unite de Genetique Mycobacterienne (CNRS URA 13000), Institut Pasteur, 25 rue du Dr Roux, 75724 Paris Cedex 15, France 
cDepartment of Science and Biomedical Technology and Biometrics, Institute of Biological Chemistry and Molecular Biology, 
University of L'Aquila, L'Aquila, Italy 
Received 3 February 1997 
Abstract Mycobacterium fallax (M. fallax) is naturally 
sensitive to many P-lactam antibiotics (MIC < 2 Ug/ml) and 
devoid of P-lactamase activity. In this paper, we show that the 
production of the P-lactamase of Mycobacterium fortuitum by 
M. fallax significantly increased the MIC values for good 
substrates of the enzyme, whereas the potency of poor substrates 
or transient inactivators was not modified. The rates of diffusion 
of p-lactams through the mycolic acid layer were low, but for all 
studied compounds the half-equilibration times were such that 
they would only marginally affect the MIC values in the absence 
of P-lactamase production. These results emphasize the impor-
tance of enzymatic degradation as a major factor in the 
resistance of mycobacteria to penicillins. 
© 1997 Federation of European Biochemical Societies. 
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Staphylococcus and Streptococcus species [6]; (iii) the mycolic 
acid layer surrounding the peptidoglycan may act as a perme-
ability barrier and protect the DD-peptidases [7]. 
The non-pathogenic M. fallax, isolated from the river Seine 
[8], is the only mycobacterial species described so far as very 
sensitive to ampicillin (MIC 0.1 ug/ml). Based on the 16S 
RNA sequence, M. fallax is phylogenetically close to M. 
chitae, M. chelonae and M. fortuitum. This nonchromogenic 
species grows rapidly at 30°C but slowly at 37°C. Interest-
ingly, M. fallax is resistant to most conventional antitubercu-
losis drugs, including isoniazid ( > 1 |tg/ml), para-aminosali-
cylic acid (PAS) ( > 10 Ug/ml), streptomycin ( > 10 Ug/mi) and 
rifampicin ( > 20 fig/ml) [9]. 
In this report, we show that a low permeability coefficient is 
not sufficient to induce resistance but that the production of 
p-lactamase can be a determining factor in this phenomenon. 
1. Introduction 
Multiple resistance to antimicrobial agents is widely respon-
sible for the increasing incidence of mycobacterial infections 
[1]. Resistance to P-lactam compounds which specifically in-
activate the DD-peptidases involved in the biosynthesis of 
peptidoglycan [2,3] is of particular interest. In mycobacteria 
such a resistance is generally attributed to the permeability 
barrier supplied by mycolic acids which form a highly hydro-
phobic outer membrane-like structure. Recently, it has also 
been demonstrated that the cell wall of mycobacteria contains 
porin-like proteins which facilitate the diffusion of hydrophilic 
molecules [4]. Moreover, the presence of P-lactamase activity 
has been reported in many pathogenic mycobacteria [5] and 
even in the presence of P-lactamase inhibitors such as clavu-
lanic acid, p-lactam antibiotics do not efficiently kill mycobac-
teria in vivo or in vitro, an observation for which three ex-
planations are usually proposed: (i) mycobacterial P-
lactamases may be insensitive to the inhibitors; (ii) the DD-
peptidases may have a low affinity for P-lactam antibiotics, a 
phenomenon similar to that described in methicillin-resistant 
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2. Materials and methods 
2.1. Bacterial strains, plasmid and culture conditions 
M. fallax is naturally sensitive to p-lactam antibiotics and devoid of 
P-lactamase activity. Using the procedure described for M. smegmatis 
mc2155 [10] this strain was transformed by electroporation with the 
Escherichia colil Mycobacterium pIPJ42* shuttle plasmid carrying a 
pblaF*-blaF fusion [11] which allows the overproduction of the M. 
fortuitum P-lactamase, yielding the M. fallax pIPJ42* strain. 
M. fallax was grown at 30°C on Miiller-Hinton agar added with 
0.2% glycerol. For liquid cultures, Miiller-Hinton broth was supple-
mented with 0.1% Tween 80 and 0.2% glycerol. Kanamycin (20 Ug/ml) 
or ampicillin (50 ug/ml) were added in cultures of the transformed 
strain. 
2.2. Antibiotics 
Kanamycin sulfate and imipenem were gifts from Merck Sharp and 
Dohme Laboratories (Rahway, NJ, USA). Other compounds were 
obtained as before [12]. 
2.3. Kinetics of extracellular and cell-bound $-lactamase production 
Precultures (100 ml) of the two M. fallax strains were grown for 72 
h at 30°C under orbital agitation. 1 ml of the preculture was added to 
300 ml of fresh medium and the culture continued under the same 
conditions. Aliquots were withdrawn at 6 h intervals. 
The progress of the culture was monitored by determining the dry 
weight and the A60o values. The p-lactamase production was meas-
ured as follows: 5 ml aliquots were centrifuged at 13000Xg for 5 min. 
The supernatant was kept on ice and the pellet resuspended in 300 ul 
of 60 raM sodium phosphate buffer pH 7.3, sonicated (three cycles of 
30 s) and centrifuged at 13000Xg for 20 min in order to separate the 
membrane fraction from the soluble material containing the periplas-
mic and cytoplasmic compartments. The P-lactamase activity was as-
sayed by measuring the initial rate of hydrolysis of a 100 uM solution 
(500 ul) of nitrocefin in 60 mM phosphate buffer pH 7.3. 
The presence of the P-lactamase in the different cellular compart-
ments was detected with the help of rabbit antibodies raised against 
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the M. fortuitum p-lactamase. 10 ug of protein of the different frac-
tions was loaded on 12% SDS-PAGE gels (10x8x0.75 cm, BioRad). 
The proteins were transferred onto Immobilon-P membranes and the 
enzyme detected by Western blotting, followed by 5-bromo 4-chloro 
3-indolyl phosphate revelation according to the Bio-Rad protocol. 
2.4. Properties of the $-lactamase 
The steady-state kinetic parameters were determined with enzyme 
produced by M. smegmatis after transformation with pIPJ42* and 
purification to homogeneity as described before [12]. 
The measurements were performed at 30°C in 50 mM sodium phos-
phate (pH 7.4) containing 20 ug/ml of bovine serum albumin and 0.2 
M KC1. Values represent averages of five different experiments per-
formed at various concentrations. The data were collected with a 
Uvikon 80 spectrophotometer linked to a Copam microcomputer 
via a RS232C interface and analyzed as before. With nitrocefin the 
kcsA and Km values were obtained by complete time-course analysis. 
The other compounds were used as inhibitors and the Km derived as 
Ki values. Subsequently, fcca.t was estimated by determining the initial 
rate at substrate saturation. With oxacillin and cefoxitin, pseudo-first 
order rate constants for accumulation of acylenzyme were determined 
by the reporter substrate method. 
On the basis of the three-step model 
E + S ^ E S ^ E S * ^ E + P 
where ES* is the acylenzyme and K' = (k-i + ki)/{k+\), the values of 
kilK' (= kcaJKm) and k$ were determined as described by Galleni et 
al. [14]. That k-i was equal to fccat was shown again by monitoring the 
hydrolysis of a 1 mM solution of the compounds [13]. 
2.5. Determination of the MICs 
When liquid cultures reached an A60o value of 0.6, an aliquot was 
diluted 105-fold in phosphate buffer and 100 ul streaked on agar 
plates containing increasing concentrations of P-lactam antibiotics 
or kanamycin. The plates were incubated at 30°C and the results 
recorded after 5 days. 
2.6. Assay of M. fallax cell wall permeability towards fi-lactam 
antibiotics 
Cell wall permeability was determined by comparing the rates of 
hydrolysis of the p-lactam compound by intact and sonicated cells 
[15]. The cells from a 350 ml culture were centrifuged, washed once 
in 60 mM phosphate buffer, pH 7.3, supplemented with 0.2 M NaCl 
and 1 mM phenylmethylsulfonyl fluoride (PMSF) and resuspended in 
35 ml of the same buffer. The dry weight of an aliquot was also 
measured. The cell suspension (100 ul) was added to 10 ml of anti-
biotic solution at different concentrations prepared in the same buffer. 
The other experimental conditions are described in Table 1. At 15 min 
intervals, aliquots (1 ml) were filtered through 0.22 um filters. The 
concentration of intact antibiotic was determined by UV spectroscopy 
at a wavelength specific to the drug (penicillins: 230 nm; nitrocefin: 
482 nm; other cephalosporins: 260 nm) [12]. Similarly, the rate of 
hydrolysis was measured after sonication (3x1 min at 0°C) of the 
cell suspension. This resulted in a disruption of 95% of the cells as 
verified by microscopy. 
The permeability coefficient was calculated by the method of Zim-
mermann and Rosselet [15] adapted for mycobacteria by Jarlier and 
Nikaido [16]. The surface/weight ratio of M. fallax (132 cm2/mg dry 
weight) was assumed to be similar to that of Salmonella typhimurium, 
an organism of similar size and shape. 
3. Results 
3.1. $-Lactamase production by M. fallax pIPJ42* and kinetic 
parameters 
Competent cells of M. fallax were prepared from an expo-
nentially growing culture. The transformation yield with 
pIPJ42* was very low (5-15 transformants per ug of D N A ) 
and attempts to create an hypercompetent mutan t of M. fal-
lax remained unsuccessful. The plasmid content of the trans-
formants was verified by electroduction in E. coli [17]. The 
production of the P-lactamase by the transformants was con-
stitutive. Most of the |3-lactamase remained cell-bound during 
the logarithmic growth phase (Fig. 1). Less than 20% of the 
enzyme was released in the medium. These results were con-
firmed by a Western blot (Fig. 2). A large proport ion of the p-
lactamase was found to be cell-bound, in good agreement with 
the observation reported by Wagner et al. [18]. 
The catalytic properties of the purified enzyme were very 
similar to those of the original enzyme produced by M. for-
tuitum itself (Table 1). Ceftazidime was not recognized by the 
enzyme. Benzylpenicillin, ampicillin, cefuroxime, cephalori-
dine, carbenicillin and cefotaxime were rather good substrates 
while cefoxitin, imipenem and oxacillin acted as poor transi-
ent inactivators due to slow hydrolysis and accumulation of 
the acylenzyme (low k3 values). 
3.2. MICs of M. fallax with and without pIPF42* 
The impact of the production of the M. fortuitum P-lactam-
ase on the M I C values of M. fallax is reported in Table 1. 
The M I C values barely increased with oxacillin and remained 
unchanged with ceftazidime, cefoxitin and imipenem. The 
antibiotic potency of these poorly recognized compounds is 
thus directly correlated to their affinity for the essential PBPs 
and their relative diffusion rate through the mycolic acid 
layer. Ceftazidime was rather inefficient when compared to 
imipenem and cefoxitin. 
Table 1 
MIC values for M. fallax strains with and without P-lactamase and kinetic parameters for the interaction between the M. fortuitum p-lactamase 
produced by M. fallax and P-lactam antibiotics 
Antibiotic 
Benzylpenicillin 
Ampicillin 
Ceftazidime 
Oxacillin 
Cefuroxime 
Cephaloridine 
Carbenicillin 
Cefotaxime 
Imipenem* 
Nitrocefin 
Cefoxitin 
MIC (ug/ml) 
M. fallax 
<2 
0.125 
75 
20 
<1.3 
<1.5 
9.5 
<1.5 
< 2 
ND 
< 2 
M. fallax pIPJ42* 
40 
48 
75 
40 
26 
30 
125 
30 
< 2 
ND 
< 2 
Km (UM) 
50±5 
200 ±20 
>1000 
170 
96 ±10 
125 ±12 
75±7 
55 ±5 
530 
160 ±16 
100 
fccat (S l) 
30±3 
60±9 
ND 
k3 = 0.048 ± 
6 ±0.6 
24±3 
3 ±0.3 
2 ±0.2 
0.16±0.01 
450 ±45 
h = 0.015 ± 
0.005 
0.002 
k^ilKm (mM
 l g" 
1000 
300 
ND 
0.3 
60 
200 
40 
40 
0.3 
2000 
0.016 
-1) 
"Value for the very similar M. smegmatis p-lactamase. 
ND = not detectable. 
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Fig. 1. Growth of M. fallax pIPJ42* strain (dry weight, A) and 
production of secreted, soluble (o) and cell-bound p-lactamase (•). 
The enzyme activity was measured as the rate of hydrolysis of nitro-
cefin in umol ml-1 minM 
The efficiency of all the other tested compounds, which 
were good substrates for the enzyme, sharply decreased in 
the presence of P-lactamase (MIC > 20 u,g/ml). 
3.3. Permeability of the cell wall of M. fallax 
The data were obtained with a culture of M. fallax pIPJ42* 
in the logarithmic phase, where most of the p-lactamase was 
cell-bound. With intact cells, less than 1% of the activity was 
released in the supernatant during the assay and the rates of 
hydrolysis of P-lactam compounds were 3-45% of those ob-
served with the sonicated extracts. The permeability coeffi-
cients were measured at different concentrations of antibiotics. 
The small variation in the calculated values indicated that 
artefacts due to the nonspecific binding of the antibiotics to 
the cell surface or to cellular debris could be excluded. 
The permeability coefficient P ranged from 2.3 nm/s for 
cefotaxime to 66 nm/s for nitrocefm indicating a relatively 
low permeability of M. fallax to all tested compounds when 
compared to Pseudomonas aeruginosa and E. coli [16] (Table 
2). 
4. Discussion 
The morphology of M. fallax is very similar to that of M. 
tuberculosis. Its cell wall contains tuberculostearic acid and di-
and tri-unsaturated oc-mycolic acids [20], a pattern which had 
not been previously described in mycobacteria. However, 
there is no evidence that the M. fallax cell wall exhibits spe-
cific permeability properties. As shown in Table 2, the perme-
ability coefficients were significantly larger than for M. chelo-
nae [16], but quite similar to those observed for M. 
tuberculosis [19]. The permeability coefficient for nitrocefm 
was somewhat lower than for E. coli (200 nm/s) but 10-fold 
larger than for P. aeruginosa (5 nm/s) whereas that for ceph-
aloridine was similar for both P. aeruginosa and M. fallax 
[20,21]. Several compounds (cefotaxime, cefuroxime, benzyl-
penicillin and ampicillin) exhibited low diffusion rates, at least 
3 orders of magnitude lower than those observed for E. coli. 
With the cephalosporins, the permeability coefficient of M. 
fallax appeared to be grossly correlated to the hydrophobicity 
of the tested compound. A similar situation appeared to pre-
vail with the two studied penicillins. However, these latter 
compounds exhibited lower diffusion rates than cephalospor-
ins of similar log Pu. Although other factors might be in-
volved, as indicated by the difference between penicillins and 
cephalosporins, these data suggest a simple diffusion process 
through the mycolic acid layer, a situation which is in contrast 
to that observed in enterobacteria and Pseudomonas, where 
porin-mediated diffusion consistently favors the more hydro-
philic compounds. These results demonstrate that a low per-
meability coefficient does not by itself account for the resist-
ance of mycobacteria. Indeed, due to the low growth rate of 
M. fallax, even those compounds which diffuse slowly exhibit 
a relatively short half-equilibration time (2.4 h for cefotaxime) 
when compared to the generation time observed here (13 h). 
In consequence, in the absence of P-lactamase production, a 
2 U.M external concentration of cefotaxime would result in a 
periplasmic concentration of 1.5 uM after 5 h. 
Under these conditions, even with a very low acylation rate 
constant of 100 M"1 s"1 for an essential PBP, 80% of the 
target enzyme would be inactivated after an additional 2.8 
h. Note that 100 MT1 s_ 1 is only 6-10-fold higher than the 
value measured for the acylation of the 'penicillin-resistant' 
PBP 2a of the methicillin-resistant Staphylococcus aureus by 
benzylpenicillin. Even with a lower generation time of 3-5 h, 
the ratio of external to periplasmic concentration of P-lactam 
would not exceed a factor of 3-4 during exponential growth. 
In consequence, it is not surprising that the MIC values for 
M. fallax with many of the p-lactams studied here were below 
2 ug/ml (about 5 uM) and these MIC values probably reflect 
the sensitivity of the most sensitive essential PBPs. In this 
respect, ceftazidime, oxacillin and, to a somewhat lesser de-
gree, carbenicillin appear to behave as poor acylating agents 
for these enzymes. The production of a P-lactamase by strain 
pIPJ42* drastically modified the situation. Indeed, if the MIC 
values for the poor substrates (kca,t/Km < 500 M
_ 1 s_1) re-
mained similar to those observed for the strain without P-
Table 2 
M. fallax cell wall permeability to P-lactam antibiotics 
Antibiotic 
Cephaloridine 
Cefotaxime 
Cefuroxime 
Nitroceftn 
Penicillin G 
Ampicillin 
Concentration 
(uM) 
41-82 
46-76 
62-74 
155-164 
470-1180 
312-650 
Dry weight 
(mg/100 ul) 
5.2 
5.2 
5.2 
5.2 
4.05 
4.05 
Permeability coefficient (nm/s) 
M. chelonae 
[19] 
1.0 
0.79 
M. tuberculosis 
[19] 
9.4 
4.9 
3.1 
M. fallax? 
27.3 
2.3 
6.4 
66 
6 
3.5 
Net charge at 
neutral pH 
Zwitterion 
-
-
-
-
-
Hydrophobicity 
(log Pu) [25] 
2.04 
-1.05 
-0.16 
2.1 
1.7 
0.96 
aS.D. values are ± 10%. 
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Fig. 2. Distribution of the p-lactamase in the different cell compartments in function of the cell growth. 1, 2 and 3 represent aliquots with-
drawn after 65, 90 and 160 h respectively. A, B and C represent the culture medium, the 'periplasm'/cytoplasm and the cell wall/membrane 
fractions respectively. The protein was visualized with the help of antibodies raised against the M. fortuitum p-lactamase. 
lactamase, those for the other antibiotics were very sharply 
increased. The M. fortuitum P-lactamase exhibits a rather 
broad spectrum of activity, including cefuroxime and cefotax-
ime among its relatively good substrates. Accordingly, the 
MIC values for compounds with kc&JKm values above 1000 
M _ 1 s_1 increased at least 20-fold. During exponential 
growth, the enzyme was mainly cell-bound, and found in 
the membrane and periplasmic fractions. During the station-
ary phase, more enzyme was secreted into the medium and the 
situation thus appears to be intermediate between those ob-
served with Gram-negative (periplasmic P-lactamase) and 
Gram-positive (membrane-bound and extracellular enzymes) 
bacteria. 
In conclusion, it does not seem that the diffusion barrier 
due to the mycolic acid layer can, per se, greatly affect the 
sensitivity of M. fallax to P-lactam antibiotics. However, in 
combination with the production of a P-lactamase, a slow 
diffusion rate can prevent the lethal action of these com-
pounds and the presence of a broad spectrum enzyme be-
comes the major cause of resistance of the strain. In conse-
quence, the exact contribution of the P-lactamase to the 
resistance of pathogenic mycobacterial species might be 
more important than previously expected and needs to be 
carefully re-evaluated. For example, allelic exchange may be 
used to knock out the gene coding for P-lactamase as de-
scribed for the urease locus in M. bovis BCG [26]. Although 
the mycobacterial P-lactamases studied so far are class A en-
zymes [12,22], they are relatively insensitive to clavulanic acid, 
and this probably accounts for the inefficiency of this inhibitor 
which has been quite useful when administered in combina-
tion with amoxycillin or ampicillin in the case of TEM or 
SHV P-lactamase producing strains. 
The interaction between P-lactams and the PBPs of M. 
fallax is currently under investigation. This should allow the 
building of a mathematical model to explain the resistance of 
mycobacteria to these antibiotics, an approach which has been 
successfully utilized in the study of p-lactamase producing 
Gram-negative strains [23,24]. 
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